Your browser doesn't support javascript.
loading
Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.
Sakamoto, Moeko; Goto, Yuka; Nagayama, Ayako; Yano, Mamiko; Sato, Shuichi; Tajiri, Yuji; Nomura, Masatoshi.
Affiliation
  • Sakamoto M; Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan.
  • Goto Y; Yame General Hospital, Yame, Japan.
  • Nagayama A; Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan.
  • Yano M; Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan.
  • Sato S; Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan.
  • Tajiri Y; Yame General Hospital, Yame, Japan.
  • Nomura M; Futata Tetsuhiro Clinic, Fukuoka, Japan.
Diabetol Int ; 13(1): 117-123, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35059247
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diabetol Int Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diabetol Int Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Japón